Osteoporosis, Arthritis and Musculoskeletal Disorders

Effect of COVID-19 on the Management of Osteoporosis

While Coronavirus illness 2019 (COVID-19) startled and invaded everyone's life, osteoporosis continues to progress. Medical resources were promptly relocated, self-isolation and telemedicine were extended, and ambulatory care services like bone densitometry and osteoporosis-focused clinics were put on hold. Progress in fracture prevention has been hampered by the fact that osteoporotic fractures with low energy injuries are more common, despite restrictions on people's mobility. As a result, we must re-engage with concerns about chronic bone health and fracture prevention. This review discusses the challenges of managing osteoporosis during the COVID-19 pandemic, emphasising the importance of implementing recommendations regarding the importance of bone fragility care, with at least those patients who are already taking antiosteoporotic drugs adhering to their medications.